The Ministry of Science and Innovation awards €4 million for the Phase 2b clinical trial with a new drug for ischemic stroke

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

The grant will support the NexTOLL project, which aims to launch a multicentre Phase 2b clinical trial to confirm the neuroprotective effect of ApTOLL in patients with acute ischemic stroke (AIS).

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Antimicrobianos e inmunomodulación, bus...

by Labo'Life

En el corazón de un ecosistema cambiante, éste es uno de los desafí...

Photos Stream